OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30064156

Jiangsu Zhengdan Chemical Industry Co Ltd

Commodity ChemicalsVerified

Jiangsu Zhengdan Chemical Industry Co Ltd maintains a strong liquidity position, with a current ratio of 20.24, indicating that its current assets significantly exceed its current liabilities. The company is effectively funded through equity, as evidenced by a debt-to-equity ratio of 0.0, and it has a low level of long-term debt, with only CNY 4,794,690 in long-term obligations. The company's free cash flow of CNY 399,585,080 and operating cash flow of CNY 1,110,122,360 support its ability to fund operations and potentially return capital to shareholders. The company's profitability is robust, with a return on equity (ROE) of 22.24% and a return on assets (ROA) of 21.37%, both of which exceed the typical thresholds for the Commodity Chemicals industry. These metrics suggest that the company is efficiently utilizing its equity and asset base to generate returns. The gross profit of CNY 859,846,400 and operating income of CNY 834,398,430 further support the company's strong operating performance. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond its primary operations in China. This lack of diversification may expose the company to regional economic or regulatory risks. The company's capital expenditures are negative, indicating that it is not investing in new long-term assets, which may suggest a focus on maintaining existing operations rather than expanding. The company's revenue growth trajectory is not explicitly provided in the latest financial data, but its strong operating cash flow and profitability suggest a stable and potentially growing business. The company's capital structure and liquidity position support its ability to sustain operations and potentially fund future growth initiatives. The company's free cash flow and operating cash flow are key indicators of its financial health and capacity to support dividends or share repurchases. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to maintain liquidity. However, the low dilution risk indicates that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders. The company's capital structure is currently stable, with no immediate pressure for equity dilution. Recent filings and transcripts do not indicate any material events that would significantly alter the company's financial position or strategic direction. The company's financial performance and risk profile remain consistent with its historical operations, and there are no disclosed regulatory or legal issues that would impact its near-term prospects.

30-day price · 300641-3.37 (-16.8%)
Low$16.51High$20.97Close$16.67As of15 May, 00:00 UTC
Profile
CompanyJiangsu Zhengdan Chemical Industry Co Ltd
Ticker300641.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Jiangsu Zhengdan Chemical Industry Co Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Jiangsu Zhengdan Chemical Industry Co Ltd maintains a strong liquidity position, with a current ratio of 20.24, indicating that its current assets significantly exceed its current liabilities. The company is effectively funded through equity, as evidenced by a debt-to-equity ratio of 0.0, and it has a low level of long-term debt, with only CNY 4,794,690 in long-term obligations. The company's free cash flow of CNY 399,585,080 and operating cash flow of CNY 1,110,122,360 support its ability to fund operations and potentially return capital to shareholders. The company's profitability is robust, with a return on equity (ROE) of 22.24% and a return on assets (ROA) of 21.37%, both of which exceed the typical thresholds for the Commodity Chemicals industry. These metrics suggest that the company is efficiently utilizing its equity and asset base to generate returns. The gross profit of CNY 859,846,400 and operating income of CNY 834,398,430 further support the company's strong operating performance. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond its primary operations in China. This lack of diversification may expose the company to regional economic or regulatory risks. The company's capital expenditures are negative, indicating that it is not investing in new long-term assets, which may suggest a focus on maintaining existing operations rather than expanding. The company's revenue growth trajectory is not explicitly provided in the latest financial data, but its strong operating cash flow and profitability suggest a stable and potentially growing business. The company's capital structure and liquidity position support its ability to sustain operations and potentially fund future growth initiatives. The company's free cash flow and operating cash flow are key indicators of its financial health and capacity to support dividends or share repurchases. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to maintain liquidity. However, the low dilution risk indicates that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders. The company's capital structure is currently stable, with no immediate pressure for equity dilution. Recent filings and transcripts do not indicate any material events that would significantly alter the company's financial position or strategic direction. The company's financial performance and risk profile remain consistent with its historical operations, and there are no disclosed regulatory or legal issues that would impact its near-term prospects.
Key takeaways
  • Jiangsu Zhengdan Chemical Industry Co Ltd has a strong liquidity position with a current ratio of 20.24.
  • The company's ROE of 22.24% and ROA of 21.37% indicate efficient use of equity and assets.
  • The company is not currently issuing new shares at a rate that would significantly dilute existing shareholders.
  • The company's revenue is concentrated in a single business segment, which may expose it to regional risks.
  • The company's capital expenditures are negative, suggesting a focus on maintaining existing operations rather than expanding.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.29B
Gross profit$859.8M
Operating income$834.4M
Net income$714.1M
R&D
SG&A
D&A
SBC
Operating cash flow$1.11B
CapEx-$66.2M
Free cash flow$399.6M
Total assets$3.34B
Total liabilities$131.3M
Total equity$3.21B
Cash & equivalents
Long-term debt$4.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.21B
Net cash-$4.8M
Current ratio20.2
Debt/Equity0.0
ROA21.4%
ROE22.2%
Cash conversion1.6%
CapEx/Revenue-2.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300641Activity
Op margin36.4%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin31.2%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin37.5%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 01:45 UTC#5dfd5d33
Source: analysis-pipeline (hybrid)Generated: 2026-05-16 01:49 UTCJob: 078ddf74